EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

CY1125739T1Undetermined Publication Date: 2026-04-17SAREPTA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CY20221100745T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-09-22
Filing Date
2022-11-23
Publication Date
2026-04-17
Estimated Expiration
2042-11-23
Patent Text Reader

Abstract

Antisense oligomer conjugates complementary to a selected target site in the human dystrophin gene for inducing exon 45 skipping are described.
Need to check novelty before this filing date? Find Prior Art